| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10872541 | FEBS Letters | 2008 | 7 Pages |
Abstract
It has been suggested that transthyretin (TTR) is involved in preventing A-Beta fibrillization in Alzheimer's disease (AD). Here, we characterized the TTR/A-Beta interaction by competition binding assays. TTR binds to different A-Beta peptide species: soluble (Kd, 28Â nM), oligomers and fibrils; diverse TTR variants bind differentially to A-Beta. Transmission electron microscopy (TEM) analysis demonstrated that TTR is capable of interfering with A-Beta fibrillization by both inhibiting and disrupting fibril formation. Co-incubation of the two molecules resulted in the abolishment of A-Beta toxicity. Our results confirmed TTR as an A-Beta ligand and indicated the inhibition/disruption of A-Beta fibrils as a possible mechanism underlying the protective role of TTR in AD.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Plant Science
Authors
R. Costa, A. Gonçalves, M.J. Saraiva, I. Cardoso,